Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor

Hye-Ra Lee1, Zsolt Toth, Young C Shin

  • 1Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Harlyne J. Norris Cancer Research Tower, 1450 Biggy Street, Los Angeles, California 90033, USA.

Journal of Virology
|April 17, 2009
PubMed

Insights

Kaposi's sarcoma-associated herpesvirus vIRF4 protein targets MDM2, a ubiquitin ligase, to degrade the tumor suppressor p53. This viral mechanism circumvents host cell cycle arrest, aiding viral replication.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Viruses trigger host defenses like interferon (IFN) and p53 pathways to block replication.
  • Kaposi's sarcoma-associated herpesvirus (KSHV) encodes viral IFN regulatory factors (vIRFs) to evade these immune responses.
  • KSHV vIRF4 uniquely does not target IFN signaling but impacts p53 regulation.

Purpose of the Study:

  • To investigate the mechanism by which KSHV vIRF4 affects host cell growth control.
  • To elucidate the interaction between KSHV vIRF4 and the p53 pathway.
  • To understand how KSHV vIRF4 contributes to viral evasion strategies.

Main Methods:

  • Investigated the interaction between KSHV vIRF4 and MDM2 E3 ubiquitin ligase.
  • Assessed the effect of vIRF4 on p53 ubiquitination and degradation.
  • Analyzed the impact of vIRF4 on MDM2 stability and autoubiquitination.

Main Results:

  • KSHV vIRF4 directly interacts with MDM2, stabilizing the ligase.
  • vIRF4 binding suppresses MDM2 autoubiquitination, increasing MDM2 stability.
  • vIRF4 expression enhances p53 ubiquitination and proteasomal degradation, inhibiting apoptosis.
  • vIRF4 facilitates p53 downregulation, circumventing host surveillance.

Conclusions:

  • KSHV vIRF4 targets and stabilizes MDM2 to promote p53 degradation.
  • This mechanism allows KSHV to suppress p53-mediated apoptosis and enhance viral replication.
  • Downregulation of p53 is a conserved strategy among KSHV vIRFs against host immunity.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...